May 11, 2020 / 12:50 PM / a month ago

BRIEF-Corbus Pharma Reports Q1 Financial Results

May 11 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* CORBUS PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND CORPORATE UPDATES

* Q1 LOSS PER SHARE $0.43

* Q1 EARNINGS PER SHARE ESTIMATE $-0.40 — REFINITIV IBES DATA

* PHASE 1 TRIAL OF CRB-4001 REMAINS ON TRACK TO INITIATE IN Q3 OF 2020

* CORBUS PHARMACEUTICALS - TOPLINE RESULTS FOR LENABASUM PHASE 3 RESOLVE-1 STUDY IN SYSTEMIC SCLEROSIS REMAIN ON SCHEDULE FOR SUMMER OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below